These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter. Baumann CR; Bassetti CL Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356 [TBL] [Abstract][Full Text] [Related]
3. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Knudsen S; Gammeltoft S; Jennum PJ Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934 [TBL] [Abstract][Full Text] [Related]
4. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Taheri S; Zeitzer JM; Mignot E Annu Rev Neurosci; 2002; 25():283-313. PubMed ID: 12052911 [TBL] [Abstract][Full Text] [Related]
5. The neurochemistry of awakening: findings from sleep disorder narcolepsy. Nishino S; Sagawa Y Int Rev Neurobiol; 2010; 93():229-55. PubMed ID: 20970008 [TBL] [Abstract][Full Text] [Related]
6. The hypothalamic peptidergic system, hypocretin/orexin and vigilance control. Nishino S Neuropeptides; 2007 Jun; 41(3):117-33. PubMed ID: 17376528 [TBL] [Abstract][Full Text] [Related]
7. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Nishino S; Kanbayashi T Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155 [TBL] [Abstract][Full Text] [Related]
8. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation. Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137 [TBL] [Abstract][Full Text] [Related]
9. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Overeem S; Scammell TE; Lammers GJ Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114 [TBL] [Abstract][Full Text] [Related]
10. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. Sutcliffe JG; de Lecea L J Neurosci Res; 2000 Oct; 62(2):161-8. PubMed ID: 11020209 [TBL] [Abstract][Full Text] [Related]
12. The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle. Salin-Pascual RJ Isr Med Assoc J; 2001 Feb; 3(2):144-6. PubMed ID: 11344826 [TBL] [Abstract][Full Text] [Related]
14. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness? Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735 [TBL] [Abstract][Full Text] [Related]
15. Hypothalamus, hypocretins/orexin, and vigilance control. Nishino S Handb Clin Neurol; 2011; 99():765-82. PubMed ID: 21056227 [TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of narcolepsy: from HLA association to hypocretin deficiency]. Klein G; Burghaus L; Diederich N Fortschr Neurol Psychiatr; 2012 Nov; 80(11):627-34. PubMed ID: 22696207 [TBL] [Abstract][Full Text] [Related]
17. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. Zhang S; Zeitzer JM; Sakurai T; Nishino S; Mignot E J Physiol; 2007 Jun; 581(Pt 2):649-63. PubMed ID: 17379635 [TBL] [Abstract][Full Text] [Related]
18. [Hypocretins: involvement in the regulation of sleep-wakefulness cycle and pathogenesis of narcolepsy]. BereziĆska M; Zawilska JB Postepy Hig Med Dosw (Online); 2007; 61():1-12. PubMed ID: 17245312 [TBL] [Abstract][Full Text] [Related]
20. The hypocretin/orexin system in health and disease. Nishino S Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]